Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Kintor Pharmaceutical Ltd ( (HK:9939) ).
Kintor Pharmaceutical Limited announced the resignation of Mr. Gao as a non-executive director due to his personal and business commitments, effective December 11, 2025. Simultaneously, Mr. Yunfei Chen has been appointed as a non-executive director, bringing extensive experience in microbiology, biochemical pharmacy, and healthcare investment, which could enhance the company’s strategic direction and strengthen its position in the pharmaceutical industry.
More about Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Limited is a company incorporated in the Cayman Islands, focusing on the pharmaceutical industry. The company, along with its subsidiaries, operates in the development and commercialization of innovative therapies for unmet medical needs.
Average Trading Volume: 3,099,421
Technical Sentiment Signal: Hold
Current Market Cap: HK$953.4M
Find detailed analytics on 9939 stock on TipRanks’ Stock Analysis page.